BIONOMICS LTD ORDINARY SHARES AUSTR (OTCMKTS:BNOEF) Shorted Shares Increased 733.33% After Market Selling

May 18, 2018 - By reb123z

Bionomics Limited (OTCMKTS:BNOEF) Logo

The stock of BIONOMICS LTD ORDINARY SHARES AUSTR (OTCMKTS:BNOEF) registered an increase of 733.33% in short interest. BNOEF’s total short interest was 12,500 shares in May as published by FINRA. Its up 733.33% from 1,500 shares, reported previously. With 69,000 shares average volume, it will take short sellers 0 days to cover their BNOEF’s short positions.

It closed at $0.416 lastly. It is down 0.00% since May 18, 2017 and is . It has underperformed by 11.55% the S&P500.

Bionomics Limited, a clinical-stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancer in Australia, France, and the United States. The company has market cap of $195.50 million. It operates through Drug Discovery and Development, and Contract Services divisions. It currently has negative earnings. The company's product pipeline includes BNC210, a novel and proprietary negative allosteric modulator, which is in Phase II clinical trial for the treatment of generalized anxiety disorder, as well as is in the initiation of a Phase II clinical trial in patients with post-traumatic stress disorder; BNC375, a small molecule therapeutics for the treatment of cognitive impairment in Alzheimer's disease; BNC101, a monoclonal antibody that targets cancer stem cells; and BNC105, a vascular disrupting agent for the treatment of cancer, as well as disrupts the blood vessels that nourish tumors in cancer treatment.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.